Literature DB >> 21339648

Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Jinjong Myoung1, Don Ganem.   

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) is a B-lymphotropic virus whose primary site of replication is the oropharynx. KSHV can infect both T and B cells from primary tonsillar explant cultures. However, T cells do not support lytic replication, while B cells spontaneously produce substantial amounts of infectious virus. Here, we provide evidence for a mechanism by which activated T cells may promote or stabilize latency of KSHV infection in B cells. When mixed cultures of B cells and activated T cells were exposed to KSHV, little spontaneous virus production was observed. Removing T cells from the mix or treating the mixed culture with immune suppressants enhanced virus production. Adding back activated T cells to purified infected B cells efficiently suppressed KSHV production, primarily due to CD4(+) T cells. This suppressive activity required T cell activation and direct cell-cell contact, but not prior exposure to KSHV antigen. Suppression was not MHC restricted and did not result in killing of the target cell. We therefore propose that oropharyngeal T cells activated by a variety of stimuli can recognize ligands on infected target B cells, leading to signaling events that prevent spontaneous lytic activation and promote latent infection in this compartment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339648      PMCID: PMC3049404          DOI: 10.1172/JCI43755

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

Review 1.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

2.  Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures.

Authors:  A B Rickinson; D J Moss; J H Pope
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

3.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.

Authors:  A B Rickinson; D J Moss; J H Pope; N Ahlberg
Journal:  Int J Cancer       Date:  1980-01-15       Impact factor: 7.396

4.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

5.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Jeffrey Vieira; Patricia M O'Hearn
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

6.  Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines.

Authors:  A G Bird; S M McLachlan; S Britton
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

7.  Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.

Authors:  Eric A Engels; Robert J Biggar; Vickie A Marshall; Michael A Walters; Christine J Gamache; Denise Whitby; James J Goedert
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

8.  Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma.

Authors:  E Martro; M Bulterys; J A Stewart; T J Spira; M J Cannon; T D Thacher; R Bruns; P E Pellett; S C Dollard
Journal:  J Med Virol       Date:  2004-01       Impact factor: 2.327

9.  Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.

Authors:  G Scala; J J Oppenheim
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

10.  Phaseolus vulgaris phytohaemagglutinin (PHA) binds to the human T lymphocyte antigen receptor.

Authors:  O P Chilson; A W Boylston; M J Crumpton
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  39 in total

1.  Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Virol Methods       Date:  2011-03-17       Impact factor: 2.014

2.  Comment on primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas (Journal of Microbiology 2017, 55(5): 319-329).

Authors:  Giovanna Rappocciolo; Frank Jenkins; Charles R Rinaldo
Journal:  J Microbiol       Date:  2017-07       Impact factor: 3.422

3.  Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Deboeeta Chatterjee; Edward A Berger
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Lela Kardava; Susan Moir; Edward A Berger
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

5.  Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 6.  Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas.

Authors:  Sangmin Kang; Jinjong Myoung
Journal:  J Microbiol       Date:  2017-04-29       Impact factor: 3.422

7.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

8.  IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response.

Authors:  Junjie Zhang; Hao Feng; Jun Zhao; Emily R Feldman; Si-Yi Chen; Weiming Yuan; Canhua Huang; Omid Akbari; Scott A Tibbetts; Pinghui Feng
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

Review 9.  Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.

Authors:  Pinghui Feng; Ashlee Moses; Klaus Früh
Journal:  Curr Opin Virol       Date:  2013-06-02       Impact factor: 7.090

Review 10.  Human viral oncogenesis: a cancer hallmarks analysis.

Authors:  Enrique A Mesri; Mark A Feitelson; Karl Munger
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.